LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 108 filers reported holding LEXICON PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 2.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $28,479 | -34.2% | 16,952 | -6.0% | 0.00% | -100.0% |
Q1 2024 | $43,289 | +77.7% | 18,037 | +13.3% | 0.00% | – |
Q4 2023 | $24,359 | +32.0% | 15,921 | -6.0% | 0.00% | -100.0% |
Q3 2023 | $18,454 | -81.9% | 16,930 | -62.0% | 0.00% | -66.7% |
Q2 2023 | $102,084 | +785161.5% | 44,578 | +694.5% | 0.00% | – |
Q1 2023 | $13 | +8.3% | 5,611 | -11.3% | 0.00% | – |
Q4 2022 | $12 | -100.0% | 6,324 | -67.4% | 0.00% | -100.0% |
Q3 2022 | $46,000 | +318.2% | 19,389 | +214.9% | 0.00% | – |
Q2 2022 | $11,000 | -67.6% | 6,157 | -62.1% | 0.00% | – |
Q1 2022 | $34,000 | +13.3% | 16,265 | +111.8% | 0.00% | -100.0% |
Q4 2021 | $30,000 | -58.9% | 7,681 | -48.8% | 0.00% | -50.0% |
Q3 2021 | $73,000 | +305.6% | 15,000 | +288.9% | 0.00% | – |
Q2 2021 | $18,000 | -50.0% | 3,857 | -37.0% | 0.00% | -100.0% |
Q1 2021 | $36,000 | +50.0% | 6,124 | -13.9% | 0.00% | 0.0% |
Q4 2020 | $24,000 | -64.2% | 7,113 | -84.8% | 0.00% | 0.0% |
Q3 2020 | $67,000 | +67.5% | 46,707 | +136.2% | 0.00% | -50.0% |
Q2 2020 | $40,000 | +122.2% | 19,778 | +356.9% | 0.00% | +100.0% |
Q4 2019 | $18,000 | +1700.0% | 4,329 | +4554.8% | 0.00% | – |
Q2 2019 | $1,000 | -85.7% | 93 | -92.3% | 0.00% | – |
Q1 2019 | $7,000 | -46.2% | 1,211 | -36.1% | 0.00% | -100.0% |
Q4 2018 | $13,000 | +85.7% | 1,894 | +205.0% | 0.00% | 0.0% |
Q3 2018 | $7,000 | -92.1% | 621 | -91.7% | 0.00% | -80.0% |
Q2 2018 | $89,000 | +2125.0% | 7,443 | +1437.8% | 0.01% | – |
Q1 2018 | $4,000 | +100.0% | 484 | +153.4% | 0.00% | – |
Q4 2017 | $2,000 | -95.1% | 191 | -94.3% | 0.00% | -100.0% |
Q3 2017 | $41,000 | +70.8% | 3,343 | +92.1% | 0.00% | 0.0% |
Q4 2016 | $24,000 | +140.0% | 1,740 | +141.7% | 0.00% | +50.0% |
Q4 2015 | $10,000 | -90.3% | 720 | -92.5% | 0.00% | -80.0% |
Q3 2015 | $103,000 | +5050.0% | 9,594 | +4446.9% | 0.01% | – |
Q2 2015 | $2,000 | – | 211 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ulys, L.L.C. | 4,321,214 | $42,694,000 | 100.00% |
Artal Group S.A. | 58,274,650 | $575,754,000 | 8.68% |
SECTOR GAMMA AS | 837,192 | $8,271,000 | 1.39% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $353,000 | 1.36% |
Virtus ETF Advisers LLC | 95,079 | $939,000 | 1.18% |
NEA Management Company, LLC | 2,382,286 | $23,537,000 | 0.98% |
USS Investment Management Ltd | 3,507,900 | $34,676,000 | 0.40% |
Malaga Cove Capital, LLC | 59,387 | $587,000 | 0.33% |
CLEARBRIDGE, LLC | 1,189,097 | $11,748,000 | 0.24% |
WEDBUSH SECURITIES INC | 139,106 | $1,374,000 | 0.17% |